Traditional fluorescence microscopy, despite its immense contributions, relies heavily on labeling cellular components with fluorescent dyes or proteins to achieve contrast and resolution beyond the diffraction limit. Such labeling, however, can introduce artifacts, potentially alter cell physiology, and is often unsuitable for prolonged live-cell observation. The advent of label-free imaging modalities attempts to circumvent these issues but usually sacrifices spatial resolution or specificity. Enter I-ISM, a technique ingeniously combining the physical principles of interferometry with image scanning microscopy to break this impasse.

At its core, I-ISM harnesses the power of coherent light interference, capitalizing on the subtle phase and amplitude variations in the scattered light from a specimen. By scanning a focused beam across the sample and collecting both amplitude and phase information with interferometric detection, this method effectively generates super-resolved images without imparting any exogenous labels. Importantly, this process preserves the natural state of live cells, enabling the visualization of organelles and sub-cellular structures in their pristine form.

The technical ingenuity lies in the integration of a Michelson-type interferometer setup with image scanning microscopy. Conventionally, image scanning microscopy improves resolution by exploiting a pinhole and a raster-scanning point illumination, which enhances both spatial resolution and signal-to-noise ratio. By embedding interferometric detection within this framework, Liang and colleagues amplify the spatial frequency content of the forward scattered light, thus attaining a resolution surpassing conventional confocal microscopy.

Their experimental setup meticulously synchronizes phase-shifting interferometry with pixel-by-pixel scanning of the cellular sample, capturing high-fidelity holographic data. The data acquisition involves capturing interferograms at each scan position, which are computationally processed to reconstruct amplitude and phase images akin to optical sectioning. This dual capturing of information enables a richer depiction of cellular morphology, highlighting minute refractive index variations within cells.

The ramifications of this technique are profound. By eliminating the reliance on fluorescent tags, I-ISM mitigates phototoxicity and photobleaching—two persistent challenges in long-term live-cell imaging. Moreover, it expands the capability to study intrinsic cellular dynamics in real-time, including organelle trafficking, membrane fluctuations, and cytoplasmic organization, all while maintaining cellular vitality and behavior fidelity.

In the course of their study, Liang et al. demonstrated I-ISM on various live cell types, revealing sub-diffraction structural details of nuclei, mitochondria, and cytoskeletal elements with clarity hitherto unattainable through label-free approaches. Their images exhibit contrast arising from natural refractive index heterogeneity, effectively mapping cellular components based on intrinsic optical properties, which opens an entirely new window into cell biology.

Furthermore, the computational algorithm designed for interferogram reconstruction employs advanced phase retrieval methods, which effectively compensate for optical aberrations and enhance image contrast. This post-processing framework ensures that the super-resolution images are free from distortions, a crucial aspect when working with delicate living specimens where experimental conditions fluctuate.

This advancement also benefits from relatively low light intensities, significantly reducing the risk of photodamage, thereby enabling extended time-lapse studies vital for monitoring cellular processes such as mitosis, migration, and intracellular transport. The non-invasive nature of I-ISM positions it as a versatile tool not only for fundamental biological research but also for clinical diagnostics, where label-free and high-resolution imaging is critically needed.

A notable advantage of interferometric image scanning microscopy is its adaptability; it can be readily integrated into existing confocal or multiphoton microscopes with minimal hardware modifications, democratizing access to super-resolution label-free imaging. This accessibility could accelerate biological discoveries across laboratories worldwide, circumventing the need for complex and expensive fluorescent probes.

In addition to biological implications, the methodology extends potential applications into materials science, where understanding the nano-scale features of transparent or weakly scattering samples is essential. The sensitivity to phase shifts allows researchers to monitor nano-topological changes, strain distributions, or minute refractive index modifications in diverse settings.

The development of I-ISM comes at a crucial time when the biological community seeks non-invasive, high-resolution imaging to unravel the secrets of living systems. As emerging data underscore the importance of nano-environmental cues and dynamic cellular interactions, tools that provide unbiased, label-free visualization at this scale are invaluable.

Looking forward, the combination of interferometric detection and adaptive optics could further refine imaging depth and resolution, facilitating three-dimensional super-resolved reconstructions of complex tissues or organoids. Such progress might also align with machine learning algorithms to enhance image interpretation and automate cellular phenotyping.

In essence, the work by Liang, Ren, and Xi charts a promising trajectory toward imaging techniques that are both gentle on living specimens and powerful in resolution, balancing optical physics ingenuity with biological utility. As the technique matures, it is poised to become a staple in cell biology, providing researchers an unfiltered view into the dynamic and multifaceted world within.

The unveiling of interferometric image scanning microscopy is more than a technical milestone; it is a conceptual leap toward understanding life at a closer and more immediate glance. This approach challenges the notion that super-resolution requires external labels and complex preparation, putting forth a vision of microscopy that respects the integrity of life as it unfolds in real-time.

In summary, I-ISM stands as a potent blend of light interference, precise scanning, and computational prowess, redefining label-free imaging’s boundaries. This breakthrough ushers in a new era where the microscope’s gaze itself is less intrusive yet infinitely more revealing, holding significant promise for biological discovery, medical diagnostics, and beyond.

Subject of Research: Live cell imaging using label-free super-resolution microscopy

Article Title: Interferometric Image Scanning Microscopy Enables Label-Free Super-Resolution Imaging of Live Cells

Article References:
Liang, Q., Ren, W. & Xi, P. Interferometric image scanning microscopy enables label-free super-resolution imaging of live cells.
Light Sci Appl 15, 248 (2026). https://doi.org/10.1038/s41377-026-02316-3

Image Credits: AI Generated

Bone marrow, the soft, spongy tissue nestled inside bones, plays a pivotal role in hematopoiesis—the process of blood cell formation—and is crucial for immune system maintenance. Despite its biological importance, detailed investigation of bone marrow microanatomy has been severely limited by its gelatinous nature combined with the rigid encasement provided by the surrounding bone matrix. Traditional imaging modalities have had to contend with either the destructive dissociation of the tissue, as in flow cytometry, or limited multiplex capability in fluorescence microscopy, constraining the scope of molecular and cellular markers that could be concurrently assessed.

In response to these challenges, the Indiana University team harnessed the power of Phenocycler 2.0™, an advanced multiplex imaging platform that allows for high-dimensional, spatially resolved analysis of tissue specimens. This next-generation instrument was deployed to chart an expansive array of 25 distinct cellular markers within intact mouse bone marrow tissue sections, enabling precise cellular phenotyping without disrupting the native tissue architecture. This level of multiplexing and preservation of tissue context has never before been achieved in bone marrow research, marking a pivotal advance in the field.

The study, which appears in the prestigious journal Leukemia, represents a notable technical leap, as stated by co-lead author Dr. Sonali Karnik. The assistant research professor of orthopedic surgery at IU School of Medicine emphasized that this unique imaging approach not only captures the intricate spatial relationships among diverse bone marrow cell populations but also accesses valuable stem cell niches critical to regenerative medicine and immune function. The technique circumvents the need to mechanically deconstruct tissue for analysis, thereby maintaining native cellular interactions central to understanding disease pathogenesis and therapeutic response.

Prior analytical methods such as flow cytometry, though extremely robust in quantifying cell populations, inherently require cell suspension preparation that destroys the tissue microenvironment and spatial context. Meanwhile, conventional fluorescence imaging techniques typically allow for only a limited number of markers—usually up to three—to be visualized simultaneously. The new multiplex imaging methodology leveraging Phenocycler 2.0 expands this capability nearly ten-fold, offering a comprehensive molecular fingerprint of the bone marrow ecosystem. This technological advantage holds the potential to decode complex pathological mechanisms that underpin hematologic diseases with greater precision.

Importantly, the IU researchers are pioneers in translating the Phenocycler 2.0 platform for mouse bone marrow analysis. While the tool has been previously utilized to image organs such as the spleen and kidney, its application within the dense and delicate bone marrow milieu posed unique challenges. The successful adaptation of this technology opens new avenues for preclinical research, especially in murine models that serve as fundamental platforms for studying human disease mechanisms and therapeutic interventions.

Co-senior author Dr. Reuben Kapur, who directs the Herman B Wells Center for Pediatric Research, highlighted the translational implications of the technique. Mouse models are central to biomedical research due to their genetic tractability and physiological relevance. By enabling detailed, multiplexed imaging of bone marrow in these models, this innovation provides researchers with a potent investigative tool to dissect complex diseases such as leukemia, autoimmune disorders, and other marrow-associated conditions. This capability will likely expedite drug discovery efforts and advance personalized therapeutic approaches.

In anticipation of the broader scientific and commercial applications of this imaging modality, the Indiana University Innovation and Commercialization Office has filed a provisional patent to protect this novel technology. Concurrent with commercialization efforts, research is underway to expand the marker panel to integrate additional components such as bone matrix proteins, neuronal elements, muscular structures, and expanded immune and signaling cell populations. This multifaceted approach seeks to deepen the biological insight obtainable from bone marrow studies, potentially enriching therapeutic target discovery.

The technical sophistication of Phenocycler 2.0 lies in its ability to conduct cyclic immunofluorescence staining and imaging, which involves repetitively labeling tissue with antibodies against different epitopes, imaging, and then chemically or photochemically stripping the labels to allow subsequent rounds. This iterative method enables the detection of an extensive array of biomarkers on the same tissue section with remarkable spatial resolution, preserving cellular and subcellular details. Such multiplex capacity is essential to unravel the heterogeneity and intercellular communications within the bone marrow niche.

Looking forward, the detailed spatial profiling enabled by this technology may offer critical insights into how microenvironmental interactions influence disease initiation, progression, and treatment resistance in hematologic malignancies and immune disorders. Researchers will be better equipped to characterize the dynamic interplay among hematopoietic stem cells, progenitor populations, stromal support cells, and infiltrating immune cells, leveraging the spatial context to inform novel diagnostic and therapeutic strategies.

The collaborative research team contributing to this study includes a multidisciplinary cadre of scientists and clinicians, each bringing specialized expertise in orthopedics, hematology, pathology, and imaging sciences. Their combined efforts underscore the interdisciplinary framework required for such technical innovations to materialize and deliver meaningful biomedical impact. Furthermore, financial support from the National Institutes of Health underpins the project’s significance and potential to drive forward the frontiers of biomedical imaging.

These advancements at Indiana University School of Medicine, the nation’s largest medical school recognized for its extensive NIH funding and innovative research, highlight its leadership in pioneering tools that bridge technological innovation and clinical relevance. Their success in developing a non-destructive, multiplexed bone marrow imaging platform not only opens new research vistas but also sets a precedent for how tissue-based analyses can evolve in the age of high-parameter imaging and precision medicine.

As the scientific community seeks to unravel the complexity of human diseases from their earliest molecular events, methodologies like the one developed at IU represent a vital step forward. This multiplex approach offers unprecedented granularity, spatial context, and biological breadth, allowing researchers to visualize the nuanced cellular environment within bone marrow, ultimately fostering breakthroughs that can translate into improved treatments and patient outcomes.

Subject of Research: Bone marrow imaging and analysis using advanced multiplex imaging technology.

Article Title: Multiplex imaging of murine bone marrow using Phenocycler 2.0™

News Publication Date: 11-Apr-2025

Web References:
Leukemia Journal Article
Indiana University School of Medicine
IU Cooperative Center of Excellence in Hematology

Image Credits: Tim Yates, IU School of Medicine

Keywords: Bone marrow, Blood diseases, Bone diseases, Autoimmune disorders, Cancer treatments